Data / Form D filings / Tetherex Pharmaceuticals Corp
Tetherex Pharmaceuticals Corp: Form D filings
Tetherex Pharmaceuticals Corp, a biotechnology company in Oklahoma City, OK, filed 5 Form D notices with the SEC between 2015 and 2020. The latest, on December 16, 2020, reports an offering of no set size with nothing sold yet to 1 investor.
Find out what Tetherex Pharmaceuticals Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 840 RESEARCH PARKWAY, SUITE 516, Oklahoma City, OK, 73104
- Phone
- (405) 319-8195
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1634581
The full lists. Form D filings in Oklahoma: 227 rows, $11.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 16, 2020 | New notice | Indefinite | $0 | Indefinite | 1 | Dec 3, 2020 | sec.gov |
| Mar 6, 2018 | New notice | $50,000,000 | $42,980,475 | $7,019,525 | 240 | Feb 20, 2018 | sec.gov |
| Oct 9, 2015 | Amendment | $4,000,000 | $4,000,000 | $0 | 30 | May 18, 2015 | sec.gov |
| Jun 17, 2015 | New notice | $4,000,000 | $600,000 | $3,400,000 | 2 | May 18, 2015 | sec.gov |
| Feb 23, 2015 | New notice | $1,262,722 | $1,262,722 | $0 | 14 | Feb 9, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Scott Rollins, Ph.D. | Executive Officer, Director | |
| Rodger McEver, M.D. | Director | |
| Richard Alvarez | Executive Officer | |
| Scott Samara | Director | |
| Philip Jones, M.D. | Director | |
| Russell Rother, Ph.D. | Executive Officer, Director | |
| Todd Foley | Director | |
| David Keiser | Director | |
| Jonathan Stocker, Ph.D. | Executive Officer |
Other biotechnology companies in Oklahoma that filed recently
- Endless Corp $100,000 · Aug 19, 2026
Every Form D from the week of Dec 14, 2020 · All recent filings in Oklahoma · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Tetherex Pharmaceuticals Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.